Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qilu Pharmaceutical (Hainan) Co., Ltd. is a leading pharmaceutical manufacturer and a core subsidiary of the Qilu Pharmaceutical Group. Based in Haikou, China, the company focuses on the production of high-end finished dosages, particularly injectables and lyophilized powders, for both domestic and international markets. Its facilities are notable for having passed rigorous inspections by the US FDA, EU EMA, and other global regulatory bodies, enabling the export of numerous products to highly regulated markets. The company's portfolio includes a wide range of oncology, cardiovascular, and anti-infective medications. Qilu Hainan plays a pivotal role in the group's internationalization strategy, maintaining a robust pipeline of generic and biosimilar products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qilu Pharmaceutical Hainanco.